BRAF and melanoma: V-Raf murine sarcoma viral oncogene homolog (BRAF) mutations have been described in 8% of cancer, with higher incidence reported in melanoma (40–60%), papillary thyroid carcinomas (30–70%), and colorectal cancers (5–20%) [1,2].